Literature DB >> 22019801

Wells' syndrome (eosinophilic cellulitis) secondary to infliximab.

Nicola Tugnet, Amgad Youssef, Andrew J Whallett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22019801     DOI： 10.1093/rheumatology/ker322

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

Review 1.  Eosinophilic Skin Diseases: A Comprehensive Review.

Authors:  Hai Long; Guiying Zhang; Ling Wang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

2.  Severe Eosinophilic Gastroenteritis in a Crohn's Disease Patient Treated With Infliximab and Adalimumab.

Authors:  Amanda Muir; Lea Surrey; Alyssa Kriegermeier; Ala Shaikhkalil; David A Piccoli
Journal:  Am J Gastroenterol       Date:  2016-03       Impact factor: 10.864

Review 3.  Cutaneous Manifestations of Reactions to Biologics.

Authors:  Iris M Otani; Amy S Levin; Aleena Banerji
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-21       Impact factor: 4.806

4.  Development of peripheral eosinophilia in inflammatory bowel disease patients on infliximab treated at a tertiary pediatric inflammatory bowel disease center is associated with clinically active disease but does not result in loss of efficacy or adverse outcomes.

Authors:  Douglas Zabrowski; Danielle Abraham; Geoffrey Rosenthal; Howard Kader
Journal:  JGH Open       Date:  2020-02-07

5.  Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant.

Authors:  Kara Heelan; John F Ryan; Neil H Shear; Conleth A Egan
Journal:  J Dermatol Case Rep       Date:  2013-12-30

Review 6.  Eosinophilic Drug Allergy.

Authors:  Merin Kuruvilla; David A Khan
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

7.  Eosinophilic cellulitis (Wells' syndrome) caused by a temporary henna tattoo.

Authors:  Hikmet Tekin Nacaroglu; Mehmet Celegen; Canan Sule Unsal Karkıner; Ilker Günay; Güllden Diniz; Demet Can
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

8.  Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis.

Authors:  Naoto Azuma; Kiyoshi Matsui; Naoaki Hashimoto; Takahiro Yoshikawa; Hajime Sano
Journal:  Intern Med       Date:  2017-06-15       Impact factor: 1.271

9.  Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis.

Authors:  Richard Hariman; Payal Patel; Jennifer Strouse; Michael P Collins; Ann Rosenthal
Journal:  Case Rep Rheumatol       Date:  2016-05-11

10.  Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist.

Authors:  Sho Hayashida; Shunsuke Sato; Yuji Shimada; Hironori Tsuzura; Yuji Ikeda; Sho Takahashi; Sho Sato; Nozomi Amano; Ayato Murata; Akihito Nagahara; Takuya Genda
Journal:  Intern Med       Date:  2020-08-15       Impact factor: 1.271
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.